Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Selective Human Sirtuin-2 Inhibitors, the Therapeutic Candidate for Huntington's Disease


Technology Benefits

More potent and selective than previous human sirtuin-2 inhibitors Improved pharmaceutical properties and promising drug candidate


Detailed Technology Description

Selective human sirtuin-2 inhibitors for use in treating Huntington's disease. #therapeutics #cns #huntingtonsdisease


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View